Last update 24 May 2025

Tazarotene/Betamethasone Dipropionate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Tazarotene and Betamethasone Dipropionate Cream, 他扎罗汀/倍他米松二丙酸酯
Target
GR x RARα x RARβ2 x RARγ
Action
agonists
Mechanism
GR agonists(Glucocorticoid receptor agonists), RARα agonists(Retinoic acid receptor alpha agonists), RARβ2 agonists(Retinoic acid receptor beta agonists)
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Psoriasis
Inactive Indication-
Originator Organization
Chongqing Huapont Pharmaceutical Co. Ltd.Chongqing Huapont Pharmaceutical Co. Ltd.
Active Organization
Chongqing Huapont Pharmaceutical Co. Ltd.Chongqing Huapont Pharmaceutical Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
China (27 Mar 2015),
Psoriasis
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC28H37FO7
InChIKeyCIWBQSYVNNPZIQ-XYWKZLDCSA-N
CAS Registry5593-20-4
View All Structures (2)

Related

1
Clinical Trials associated with Tazarotene/Betamethasone Dipropionate
CTR20160731
/ CompletedPhase 4
他扎罗汀倍他米松乳膏治疗慢性斑块型银屑病的Ⅳ期临床研究
[Translation] Phase IV clinical study of tazarotene-betamethasone cream in the treatment of chronic plaque psoriasis
100 Clinical Results associated with Tazarotene/Betamethasone Dipropionate
Login to view more data
100 Translational Medicine associated with Tazarotene/Betamethasone Dipropionate
Login to view more data
100 Patents (Medical) associated with Tazarotene/Betamethasone Dipropionate
Login to view more data
100 Deals associated with Tazarotene/Betamethasone Dipropionate
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
D05
-

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Psoriasis
China
Chongqing Huapont Pharmaceutical Co. Ltd.Chongqing Huapont Pharmaceutical Co. Ltd.
27 Mar 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free